Published in Eur Heart J on May 01, 2001
Predicting left ventricular recovery after replacement of a regurgitant aortic valve in pediatric and young adult patients: is it ever too late? Pediatr Cardiol (2012) 0.80
Normal ranges and physiological changes of midwall fractional shortening in healthy korean population. Korean Circ J (2010) 0.75
Echocardiography predicts adverse cardiac remodelling in heart failure. Exp Clin Cardiol (2004) 0.75
Predictors of long-term survival after valve replacement for chronic aortic regurgitation. Eur Heart J (2001) 0.75
Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol (2000) 6.77
Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem (1999) 6.59
Isolated noncompaction of the myocardium in adults. Mayo Clin Proc (1997) 4.63
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59
Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation (2001) 3.38
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med (2000) 3.09
Acute heart transplant rejection due to Saint John's wort. Lancet (2000) 2.71
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation (1994) 2.69
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation (1997) 2.51
Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass. Lancet (1991) 2.50
Primary pulmonary hypertension in HIV infection. Chest (1991) 2.40
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension (1986) 2.30
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation (1998) 2.27
Surgical treatment of acquired left ventricular pseudoaneurysms. Ann Thorac Surg (2000) 2.23
N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Eur J Clin Invest (2007) 2.06
Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation (1996) 2.05
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 1.98
Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation (1991) 1.96
Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation (2000) 1.93
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79
Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J (2004) 1.76
Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med (2000) 1.70
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
Dynamic left ventricular outflow tract obstruction evoked by exercise echocardiography: prevalence and predictive factors in a prospective study. Eur J Echocardiogr (2008) 1.65
[True aneurysm of the ascending aorta in HIV disease]. Schweiz Med Wochenschr (1994) 1.63
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest (1998) 1.62
[Interrupted aortic arch: fortuitous diagnosis in a 72-year-old female patient with severe aortic insufficiency]. Schweiz Med Wochenschr (1995) 1.61
Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol (1991) 1.58
Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol (1998) 1.58
Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg (2000) 1.55
Pre- and postoperative findings in patients with endomyocardial fibrosis. Br Heart J (1978) 1.55
Hyperthyroidism and pulmonary hypertension. J Intern Med (1997) 1.54
Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest (1996) 1.50
Spontaneous course of aortic valve disease. Eur Heart J (1987) 1.50
Improved distal circulatory support for repair of descending thoracic aortic aneurysms. Ann Thorac Surg (1993) 1.49
Congenital aortopulumonary window: diagnosis, surgical technique and long-term results. Eur J Cardiothorac Surg (1997) 1.49
Cardiac surgery for Kartagener syndrome. Pediatr Cardiol (1997) 1.48
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension (1990) 1.47
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47
Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation (1989) 1.47
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47
Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly (2001) 1.46
Endothelin. Key to coronary vasospasm? Circulation (1991) 1.46
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart (2007) 1.45
Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2000) 1.45
Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin versus ceftriaxone. World J Surg (1990) 1.45
Aging, serum estradiol levels, and pregnancy differentially affect vascular reactivity of the rat uterine artery. J Soc Gynecol Investig (2000) 1.44
Futility of pericardiectomy for postirradiation constrictive pericarditis? Ann Thorac Surg (1990) 1.44
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 1.43
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation (1990) 1.42
ICD implantation with and without combined myocardial revascularisation--incidence of ICD therapy and late survival. Thorac Cardiovasc Surg (2002) 1.42
Transoesophageal echocardiography is unreliable for cardiac output assessment after cardiac surgery compared with thermodilution. Anaesthesia (2004) 1.41
Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2001) 1.41
Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension (1997) 1.41
[Stress echocardiography--principles, methodology, results and indications]. Ther Umsch (1997) 1.40
Indications for pericardial glutaraldehyde-preserved xenograft in repair of congenital heart disease. J Card Surg (1989) 1.40
Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.40
Persisting myocardial sinusoids of both ventricles as an isolated anomaly: echocardiographic, angiographic, and pathologic anatomical findings. Cardiovasc Intervent Radiol (1986) 1.39
Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res (1999) 1.39
[Chest pain, dyspnea, syncope]. Praxis (Bern 1994) (1995) 1.39
Images in cardiovascular medicine. Idiopathic hypereosinophilic vasculitis. Circulation (1995) 1.39
Emergency repair of incidentally diagnosed ascending aortic aneurysm immediately after caesarean section. Br J Anaesth (1999) 1.39
[Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions]. Schweiz Med Wochenschr (1997) 1.39
Brief report: reuse of a transplanted heart. N Engl J Med (1993) 1.38
Echo-free perfused spaces: a current postoperative finding after homograft replacement of the aortic valve. J Thorac Cardiovasc Surg (1994) 1.38
New approach to patency and flow assessment after left internal thoracic artery hypoperfusion syndrome with additional saphenous vein graft to the left anterior descending artery with phase-contrast magnetic resonance angiography. J Thorac Cardiovasc Surg (1997) 1.38
Infected endocardial pacemaker electrodes: successful open intracardiac removal. Pacing Clin Electrophysiol (1993) 1.38
Prognosis of medically treated patients referred for cardiac transplantation. Int J Cardiol (1998) 1.38
Propionibacterium acnes as a cause of aggressive aortic valve endocarditis and importance of tissue grinding: case report and review. J Clin Microbiol (1994) 1.38
Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37
Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res (2001) 1.36
Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation (2000) 1.35
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med (1997) 1.35
Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest (1995) 1.34
Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension (1995) 1.34
Nifedipine for high altitude pulmonary oedema. Lancet (1989) 1.32
The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol (1995) 1.32
Continuous versus bolus thermodilution cardiac output measurements--a comparative study. Crit Care Med (1995) 1.32
Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension (1987) 1.30
Reoperations after operation on the thoracic aorta: etiology, surgical techniques, and prevention. Ann Thorac Surg (1993) 1.29
[Heart tumors: incidence, distribution, diagnosis. Exemplified by 20,305 echocardiographies]. Schweiz Med Wochenschr (1991) 1.28
Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol (1990) 1.28
Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation (1995) 1.27
Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (1998) 1.26
Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart (1999) 1.26
Compliance in hypertension: facts and concepts. J Hypertens Suppl (1985) 1.25
Dealing with dilated ascending aorta during aortic valve replacement: advantages of conservative surgical approach. Eur J Cardiothorac Surg (1991) 1.25